As of 2025-11-23, the Intrinsic Value of Surgery Partners Inc (SGRY) is 22.27 USD. This SGRY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 15.84 USD, the upside of Surgery Partners Inc is 40.60%.
The range of the Intrinsic Value is 15.78 - 31.85 USD
Based on its market price of 15.84 USD and our intrinsic valuation, Surgery Partners Inc (SGRY) is undervalued by 40.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 15.78 - 31.85 | 22.27 | 40.6% |
| DCF (Growth 10y) | 23.99 - 38.89 | 30.01 | 89.4% |
| DCF (EBITDA 5y) | 5.56 - 19.75 | 13.62 | -14.0% |
| DCF (EBITDA 10y) | 13.66 - 26.36 | 20.89 | 31.9% |
| Fair Value | -7.04 - -7.04 | -7.04 | -144.42% |
| P/E | (27.41) - 18.02 | (5.45) | -134.4% |
| EV/EBITDA | 0.38 - 34.43 | 16.43 | 3.7% |
| EPV | 25.55 - 25.18 | 25.36 | 60.1% |
| DDM - Stable | (8.59) - (19.86) | (14.23) | -189.8% |
| DDM - Multi | 6.86 - 12.56 | 8.89 | -43.8% |
| Market Cap (mil) | 2,030.85 |
| Beta | 0.99 |
| Outstanding shares (mil) | 128.21 |
| Enterprise Value (mil) | 5,355.95 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.92% |
| Cost of Debt | 7.23% |
| WACC | 7.08% |